Dose fractionation and early response in oligometastatic brain metastases: a retrospective comparison of stereotactic versus hypofractionated radiotherapy

Background

Brain metastases are the most common intracranial malignancies and significantly affect survival and quality of life. In patients with limited brain metastases, stereotactic radiotherapy has become an important local treatment option; however, the optimal fractionation strategy remains unclear.